Luft, Thomas http://orcid.org/0000-0002-0387-1640
Dreger, Peter http://orcid.org/0000-0002-7429-8570
Radujkovic, Aleksandar http://orcid.org/0000-0002-8543-5016
Article History
Received: 1 February 2021
Revised: 8 June 2021
Accepted: 22 June 2021
First Online: 12 July 2021
Competing interests
: T.L. and A.R. have nothing to disclose. P.D.: consultancy for AbbVie, AstraZeneca, bluebird bio, Gilead, Janssen, Novartis, Riemser, Roche; speakers bureau for AbbVie, AstraZeneca, Gilead, Novartis, Riemser, Roche; research support from Riemser.